United Therapeutics Corporation uses strong cash flows to develop xenotransplanted organs and solve global supply shortages.
Tribune Content Agency on MSN
Ask the doctors: New drugs transform Alzheimer’s research
Dear Doctors: I understand that there is treatment for the beginning stages of Alzheimer's disease that can stave off serious decline. There are also new tests to determine if a person is in the ...
Omnicell (NASDAQ:OMCL) reported what management described as a “solid finish” to fiscal year 2025, with fourth-quarter total ...
The 5-Year Risk Score: New AI tools can analyze your current “normal” tissue to identify hidden biomarkers of future risk.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, ...
Despite its strong influence, APOE is not the sole cause of Alzheimer’s or other dementias. Even among people with the ...
Bob Shaw glared at the executives from the chemical giant 3M across the table from him. He held up a carpet sample and ...
Morning Overview on MSN
Leftover COVID-19 fragments found silently killing key immune cells
Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...
News Medical on MSN
Weak governance hinders One Health outbreak response in Africa
Across Africa, One Health is endorsed at the top but often breaks down where outbreaks start, writes Albert Ansah. Despite ...
Global Healthcare Video Conferencing Solutions Market size is expected to be worth around US$ 132.6 Billion by 2033.
Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...
Health education, particularly at the school level, is highlighted as a long-term prevention strategy with multiplier effects across generations. Teaching basic hygiene, critical health literacy, and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果